Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
If youre ready to take control of your health and start feeling your best, its time to book a consultation with us
*FOR WEIGHT-LOSS MEDICATION BMI SOURCE: National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK)
Nonetheless, future studies should prioritize the development or adoption of specialized tools designed specifically for this clinical profile, ensuring these are subjected to comprehensive psychometric validation
Documented areas of investigation include: Dual GIP/GLP-1 receptor co-activation and comparative downstream cAMP signalling Glucose-stimulated insulin secretion (GSIS) assays in pancreatic beta-cell cultures Adipogenesis modulation and lipid turnover studies in adipocyte models Body composition and energy balance experiments in diet-induced obesity (DIO) animal models Receptor selectivity profiling versus selective GIP and GLP-1 reference agonists Comparative pharmacokinetic studies examining half-life extension via fatty acid acylation Hypothalamic appetite signalling pathway investigations in rodent models Product Specifications Storage & Handling For preservation of research integrity, Tirzepatide 30mg should be stored at 20C in its original sealed vial, protected from light and moisture
US$ 26.77
US$ 24.66
US$ 21.75
US$ 29.74
